Age of Risk: Biologicals

Approving new drugs is a risky business. Despite best efforts (and frankly, some less than best efforts), newly approved drugs frequently turn out to have unexpected toxicities. One example is unexpected heart toxicity associated with the use of the common pain-killers like rofecoxib (i.e. Vioxx).  Another is the surprising heart toxicity associated with the wonder… Continue reading Age of Risk: Biologicals